Integral Derivatives’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-149,830
Closed -$2.97M 862
2017
Q4
$2.76M Buy
149,830
+95,370
+175% +$1.87M 0.05% 223
2017
Q3
$1.01M Buy
+54,460
New +$884K 0.02% 495
2017
Q2
Sell
-38,920
Closed -$571K 1193
2017
Q1
$500K Buy
38,920
+13,000
+50% +$153K 0.01% 742
2016
Q4
$274K Buy
+25,920
New +$263K 0.01% 911
2016
Q2
Sell
-33,010
Closed -$265K 1037
2016
Q1
$273K Sell
33,010
-89,230
-73% -$649K 0.01% 663
2015
Q4
$971K Sell
122,240
-118,000
-49% -$887K 0.02% 475
2015
Q3
$1.57M Buy
240,240
+155,000
+182% +$1.14M 0.04% 372
2015
Q2
$693K Sell
85,240
-119,920
-58% -$942K 0.02% 634
2015
Q1
$1.44M Buy
+205,160
New +$1.62M 0.03% 392

Other funds holding LRCX

Integral Derivatives's LRCX Position: Q1 2018 in Review

Integral Derivatives sold out of Lam Research (LRCX) in Q1 2018, closing a stake of 149,830 shares — an estimated $2.97M sold.

Integral Derivatives first reported a position in LRCX in Q1 2015 and held it in 9 quarters. The position peaked at $2.76M in Q4 2017. 920 funds tracked by Wall St. Rank hold LRCX as of Q1 2018.

  • Integral Derivatives reported no remaining Lam Research position as of Q1 2018 after selling out during the quarter.
  • Integral Derivatives sold 149,830 Lam Research shares in Q1 2018, an estimated $2.97M.
  • Integral Derivatives first reported a position in Lam Research in Q1 2015 and held it in 9 quarters.
  • Integral Derivatives's Lam Research position peaked at $2.76M in Q4 2017.
  • 920 funds tracked by Wall St. Rank held Lam Research as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.